88 related articles for article (PubMed ID: 6160912)
1. Combination chemotherapy with cyclophosphamide, doxorubicin, and bleomycin for metastatic transitional cell carcinoma of the urinary tract.
Levi JA; Aroney RS; Dalley DN
Cancer Treat Rep; 1980; 64(8-9):1011-3. PubMed ID: 6160912
[TBL] [Abstract][Full Text] [Related]
2. Phase II trial cisplatin, doxorubicin, and cyclophosphamide (CAP) in the treatment of urothelial transitional cell carcinoma.
Campbell M; Baker LH; Opipari M; Al-Sarraf M
Cancer Treat Rep; 1981; 65(9-10):897-9. PubMed ID: 7196800
[TBL] [Abstract][Full Text] [Related]
3. [Chemotherapy in advanced transitional cell carcinoma of the urinary tract. Phase II trial of a combination of doxorubicin and cisplatin].
Ribrag V; Ghnassia M; Théodore C; Ghosn M; Piot G; Beurton D; Cukier J; Droz JP
J Urol (Paris); 1990; 96(7):373-4. PubMed ID: 2290037
[TBL] [Abstract][Full Text] [Related]
4. Methotrexate and mitomycin for patients with metastatic transitional cell carcinoma of the urinary tract.
Tannock IF
Cancer Treat Rep; 1983 May; 67(5):503-4. PubMed ID: 6406061
[TBL] [Abstract][Full Text] [Related]
5. Phase II study of 5-fluorouracil and adriamycin in transitional cell carcinoma of the urinary tract.
Martino S; Samal B; Al-Sarraf M
Cancer Treat Rep; 1980 Jan; 64(1):161-3. PubMed ID: 7379051
[TBL] [Abstract][Full Text] [Related]
6. Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease.
Montoto S; Camós M; López-Guillermo A; Bosch F; Cervantes F; Blandé J; Esteve J; Cobo F; Nomdedeu B; Campo E; Montserrat E
Cancer; 2000 May; 88(9):2142-8. PubMed ID: 10813727
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report.
Gohji K; Higuchi A; Maruyama S; Minayoshi K; Fujii A; Itoh N; Hasunuma Y; Tanaka H; Izumi T
Jpn J Clin Oncol; 1993 Oct; 23(5):291-8. PubMed ID: 7693990
[TBL] [Abstract][Full Text] [Related]
8. [A study of the use of methotrexate, vincristine, cis-platinum, cyclophosphamide, adriamycin, bleomycin (MVP-CAB) in metastatic transitional cell carcinoma].
Fujii A; Den S; Nakamura I; Ohshima H; Nagata H; Izumi T; Takechi Y; Kawaida T; Kamidono S; Yasuno H
Hinyokika Kiyo; 1987 May; 33(5):697-703. PubMed ID: 2444083
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy of metastatic bladder cancer.
Yagoda A
Cancer; 1980 Apr; 45(7 Suppl):1879-88. PubMed ID: 7189443
[No Abstract] [Full Text] [Related]
10. Scheduled and unscheduled combination chemotherapy in the treatment of squamous cell lung cancer (cyclophosphamide, adriamycin, vincristine and bleomycin, with and without cis-platinum).
Jones DH; Bleehen NM; Grant RM; Plowman PN; Roberts JT; Sikora K; Watson JV; Wiltshire CR
Anticancer Res; 1983; 3(4):235-8. PubMed ID: 6192751
[TBL] [Abstract][Full Text] [Related]
11. Sequential combination chemotherapy and surgery for disseminated testicular cancer: cis-dichlorodiammineplatinum(II), vinblastine, and bleomycin remission-induction therapy followed by cyclophosphamide and adriamycin.
Garnick MB; Canellos GP; Richie JP; Stark JJ
Cancer Treat Rep; 1979; 63(9-10):1681-6. PubMed ID: 91438
[TBL] [Abstract][Full Text] [Related]
12. [Chemotherapy of metastatic urothelial carcinoma].
Kihara K; Sakuramoto T; Washizuka M; Kawai T; Ogawa M
Gan To Kagaku Ryoho; 1982 Nov; 9(11):2046-7. PubMed ID: 6892194
[TBL] [Abstract][Full Text] [Related]
13. [PPA (cis-platinum), peplomycin and adriamycin) combination chemotherapy in transitional cell carcinoma of the urothelial tract--pilot study].
Ono Y; Ohshima S; Fujita T; Naide Y; Suzuki K; Asoh Y; Fukushima M; Ohta K
Nihon Gan Chiryo Gakkai Shi; 1986 Feb; 21(1):28-33. PubMed ID: 2422307
[No Abstract] [Full Text] [Related]
14. Combination chemotherapy for metastatic urinary bladder cancer with 5-FU, vincristine, bleomycin, cyclophosphamide, mitomycin, and methotrexate.
Kubota Y; Shuin T; Miura T; Moriyama M; Fukushima S; Shiozaki H; Ooshima H
Cancer Treat Rep; 1984 Sep; 68(9):1167-8. PubMed ID: 6206946
[TBL] [Abstract][Full Text] [Related]
15. [Combination chemotherapy with M-VAC protocol in metastatic urothelial cancer].
Sella A; Flex D; Gafni D; Rabinovitz O; Sulkes A; Baniel J
Harefuah; 1999 Feb; 136(4):268-71, 340, 339. PubMed ID: 10914214
[TBL] [Abstract][Full Text] [Related]
16. A study of cyclophosphamide, adriamycin, cis-platinum, and methotrexate in advanced transitional cell carcinoma of the urinary tract.
Citrin DL; Hogan TF; Davis TE
Cancer; 1983 Jan; 51(1):1-4. PubMed ID: 6681590
[TBL] [Abstract][Full Text] [Related]
17. [A study of combination chemotherapy with cis-diamminedichloroplatinum for advanced genitourinary carcinoma].
Nakatsu H; Nishimoto K; Moriyama H; Ehara S; Igawa M; Ishino T; Kodama M; Fujii M; Ukai R; Nihira H
Gan To Kagaku Ryoho; 1982 Apr; 9(4):702-9. PubMed ID: 6892199
[TBL] [Abstract][Full Text] [Related]
18. Single-agent and combination chemotherapy for extensive non-small cell carcinomas of the lung.
Davis S; Pandya MR; Rambotti P
Cancer Treat Rep; 1980; 64(4-5):685-8. PubMed ID: 6253067
[TBL] [Abstract][Full Text] [Related]
19. Preliminary results of M-VAC chemotherapy combined with mild hyperthermia, a new therapeutic strategy for advanced or metastatic transitional cell carcinoma of the urothelium.
Yamada Y; Itoh Y; Aoki S; Nakamura K; Taki T; Naruse K; Tobiume M; Zennami K; Katsuda R; Kato Y; Watanabe M; Nishikawa G; Minami M; Nakahira M; Ukai S; Sawada M; Kitamura A; Honda N
Cancer Chemother Pharmacol; 2009 Nov; 64(6):1079-83. PubMed ID: 19277660
[TBL] [Abstract][Full Text] [Related]
20. CAP (cyclophosphamide, doxorubicin, and cisplatin) regimen in adrenal cortical carcinoma.
van Slooten H; van Oosterom AT
Cancer Treat Rep; 1983 Apr; 67(4):377-9. PubMed ID: 6687835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
